JAMA: Med-school officials risk conflicts by serving on pharma boards

Save

Much has been made recently over the potential conflicts of interest that arise when doctors take speaking fees from pharma companies. But as a new report suggests, some companies are shelling out a whole lot more to keep medical school and hospital leaders on their boards–where conflicts-of-interest could be much further-reaching.